Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 200 clinical trials
Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

Unresectable or Metastatic Biliary Tract Cancer

cisplatin/gemcitabine
gemcitabine
biliary tract cancer
antivirals
neutrophil count
  • 0 views
  • 24 Jan, 2021
  • 1 location
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

This study will evaluate the efficacy and safety of intravenous RC48-ADC in patients with locally advanced or metastatic HER2 overexpressed biliary tract cancer who have failed first-line

fluorouracil
gemcitabine
biliary tract cancer
neutrophil count
cholangiocarcinoma
  • 0 views
  • 23 Sep, 2021
  • 16 locations
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)

This research is studying the effect of the combination of how two study drugs (Nivolumab and DKN-01) works in people with advanced biliary tract cancer.

extrahepatic cholangiocarcinoma
nivolumab
radiofrequency ablation
biliary tract cancer
antivirals
  • 9 views
  • 28 Jan, 2021
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

patients with unresectable or metastatic biliary tract cancer (BTC). About 298 subjects are randomly assigned to two study treatment groups in the ratio of 1:1 by Interactive Web Response System (IWRS

extrahepatic cholangiocarcinoma
progressive disease
gemcitabine
biliary tract cancer
combination chemotherapy
  • 9 views
  • 23 Jan, 2021
  • 1 location
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

The purpose of this research study is to determine the safety and efficacy of CPI-613 (devimistat) in the treatment of advanced biliary tract cancer when used in combination with standard of

carcinoma
cisplatin/gemcitabine
measurable disease
gemcitabine
biliary tract cancer
  • 1 views
  • 11 Jun, 2021
  • 7 locations
Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

Investigators hypothesize that following first-line platinum based chemotherapy, rucaparib in combination with nivolumab, will improve progression-free survival and overall survival in BTC patients.

ffpe
biliary tract cancer
adenocarcinoma
measurable disease
nivolumab
  • 10 views
  • 28 Jan, 2021
  • 2 locations
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Target population: patients with advanced biliary tract cancer (including gallbladder carcinoma, intrahepatic and extrahepatic cholangiocarcinoma) . Primary objective

  • 0 views
  • 22 Jan, 2021
  • 1 location
DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients who have failed to 1st-line chemotherapy.

serum bilirubin
ampullary carcinoma
biliary tract cancer
MRI
ampulla of vater cancer
  • 0 views
  • 30 Sep, 2021
  • 1 location
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Considering that the poor prognosis of resected biliary tract cancer and negative impact on the survival outcomes of R1/R2 resection, neoadjuvant chemotherapy may improve R0 resection rates and

cisplatin/gemcitabine
malignant disease
gemcitabine
pet scan
biliary tract cancer
  • 1 views
  • 02 Aug, 2021
  • 1 location
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

This research study is studying a combination of drugs as a possible treatment for Hepatocellular Carcinoma or Biliary Tract Cancer. The interventions involved in this study are:

hepatitis
antiviral drugs
tremelimumab
gemcitabine
biliary tract cancer
  • 23 views
  • 02 May, 2021
  • 1 location